Silencing of CircTRIM25/miR-138-5p/CREB1 axis promotes chondrogenesis in osteoarthritis

Chunlei He1, Zhaogan Zeng2, Yadong Yang1

  • 1Department of Orthopedics, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.

Autoimmunity
|July 15, 2024
PubMed
Abstract

Insights

Silencing circular RNA TRIM25 (circTRIM25) inhibits chondrocyte ferroptosis and inflammation, thereby slowing osteoarthritis progression. This occurs through the miR-138-5p/CREB pathway, offering a potential therapeutic target for OA.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Dysregulated circular RNAs (circRNAs) are implicated in osteoarthritis (OA) pathogenesis.
  • Investigating specific circRNAs like hsa_circ_0044719 (circTRIM25) is crucial for understanding OA progression.

Purpose of the Study:

  • To elucidate the role of circTRIM25 in chondrocyte ferroptosis.
  • To explore the underlying molecular mechanisms involving miR-138-5p and CREB1.

Main Methods:

  • Chondrocytes were stimulated with IL-1β to model OA.
  • Quantitative real-time PCR, luciferase reporter assays, and RNA pull-down assays were used to analyze gene expression and interactions.
  • Cellular viability, ferroptosis, and inflammation markers were assessed using various assays.

Main Results:

  • CircTRIM25 expression was elevated in OA tissues and IL-1β-treated chondrocytes.
  • Knockdown of circTRIM25 reduced chondrocyte ferroptosis and inflammation, and attenuated cartilage damage in vivo.
  • CircTRIM25 acts as a sponge for miR-138-5p, which targets CREB1, revealing a regulatory axis.

Conclusions:

  • Silencing circTRIM25 ameliorates OA by inhibiting chondrocyte ferroptosis via the circTRIM25/miR-138-5p/CREB1 pathway.
  • CircTRIM25 represents a potential therapeutic target for osteoarthritis treatment.